Premium
Expression of human GITRL on myeloid dendritic cells enhances their immunostimulatory function but does not abrogate the suppressive effect of CD4 + CD25 + regulatory T cells
Author(s) -
Tuyaerts Sandra,
Van Meirvenne Sonja,
Bonehill Aude,
Heirman Carlo,
Corthals Jurgen,
Waldmann Herman,
Breckpot Karine,
Thielemans Kris,
Aerts Joeri L.
Publication year - 2007
Publication title -
journal of leukocyte biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1189/jlb.0906568
Subject(s) - biology , il 2 receptor , function (biology) , myeloid cells , myeloid , microbiology and biotechnology , immunology , cancer research , t cell , immune system
CD4 + CD25 + regulatory T cells (Treg) have been described as an important hurdle for immunotherapy. Engagement of glucocorticoid‐induced TNF receptor‐related protein (GITR) has emerged recently as an important mechanism to control the suppression of CD4 + CD25 + Treg. Furthermore, it has been documented extensively that GITR ligation is costimulatory for naive and activated T cells in the murine setting. However, little is known about the role of the human GITR ligand (huGITRL). We wanted to explore whether huGITRL could enhance antigen‐specific T cell priming by dendritic cells (DC). First, we confirmed the endogenous expression of GITRL on HUVEC. We also detected GITRL expression on EBV‐B cell lines, whereas no GITRL expression was observed on human monocyte‐derived DC. Electroporation of GITRL mRNA in monocyte‐derived DC resulted in a strong and long‐lasting surface expression of GITRL. In contrast to data obtained in mice, no significant abrogation of Treg suppression by GITRL‐expressing human DC was observed. Consistent with our mouse data, we showed that huGITRL is costimulatory for responder T cells. Furthermore, we found that GITRL‐expressing DC primed increased numbers of Melan‐A‐specific CD8 + T cells. We conclude that although huGITRL is not capable of alleviating Treg suppression of responder T cells, huGITRL overexpression on monocyte‐derived DC enhances their capacity to induce antigen‐specific T cell responses. Thus, GITRL incorporation in DC might improve the antitumor immune response after vaccination.